Murray Stewart
CIK: 0001723450
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 10, 2026CAMP
Camp4 Therapeutics Corp
Award(A)DirectStock Option (Right to Buy)
28K shares- - Jan 1, 2026XFOR
X4 Pharmaceuticals, Inc
Award(A)DirectStock Option (right to buy)
110K shares- - Jun 9, 2025XFOR
X4 Pharmaceuticals, Inc
Award(A)Direct1.5K shares- - Mar 17, 2025CAMP
Camp4 Therapeutics Corp
Award(A)DirectStock Option (Right to Buy)
17.8K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 10, 2026 |  CAMP Camp4 Therapeutics Corp | Award(A) Stock Option (Right to Buy) | 28,000 | - | - | Direct |
| Jan 1, 2026 |  XFOR X4 Pharmaceuticals, Inc | Award(A) Stock Option (right to buy) | 110,000 | - | - | Direct |
| Jun 9, 2025 | XFOR X4 Pharmaceuticals, Inc | Award(A) | 1,500 | - | - | Direct |
| Mar 17, 2025 | CAMP Camp4 Therapeutics Corp | Award(A) Stock Option (Right to Buy) | 17,787 | - | - | Direct |
1-4 of 4 transactions
About Stewart Murray
Stewart Murray (SEC CIK 0001723450) files insider reports with the SEC as Director of Camp4 Therapeutics Corp (CAMP) and Director of X4 Pharmaceuticals, Inc (XFOR).
Signal8 holds 5 ownership filings by Stewart Murray (1 Form 3, 4 Form 4), filed between Mar 19, 2025 and Jun 12, 2026. Those filings report 4 transactions, from Mar 17, 2025 to Jun 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Stewart Murray's filings is in CAMBRIDGE, MA.
Recent filings by Stewart Murray
Other insiders filing for Camp4 Therapeutics Corp (CAMP)
- Gold Kelly, Chief Financial Officer
- Schwab Andrew J., Director
- Tardiff Daniel, Chief Scientific Officer
- 5AM Partners VI, LLC, 10% Owner
- Young Richard A, Director
- Maricich Yuri, Chief Medical Officer